TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Results of Operations and Financial Condition
Item 2.02
|
Results of Operations and Financial Condition. |
On May 15, 2017, Tonix Pharmaceuticals Holding Corp. (the
Company) announced its operating results for the first fiscal
quarter ended March 31, 2017. A copy of the press release that
discusses this matter is filed as Exhibit 99.01 to, and
incorporated by reference in, this report. The information in
this Current Report is being furnished and shall not be deemed
filed for the purposes of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that
Section. The information in this Current Report shall not be
incorporated by reference into any registration statement or
other document to the Securities Act of 1933, except as shall be
expressly set forth by specific reference in any such filing.
| Item 7.01 | Regulation FD Disclosure. |
The Company intends to utilize an updated investor presentation
to conduct meetings with investors, stockholders and analysts and
at investor conferences, and which the Company intends to place
on its website, which may contain non-public information.A copy
of the presentation is filed as Exhibit 99.02.
The information contained in Item 7.01 of this Current Report on
Form 8-K, including Exhibit 99.02, is furnished to, and shall not
be deemed to be filed for the purposes of, Section 18 of the
Securities Exchange Act of 1934, as amended, or otherwise subject
to the liabilities of that section.The information contained in
Item 7.01 of this Current Report shall not be incorporated by
reference into any registration statement or any other document
filed to the Securities Act of 1933, as amended, except as
otherwise expressly stated in such filing.By filing this Current
Report on Form 8-K and furnishing the information contained in
this Item 7.01, including Exhibit 99.02, the Company makes no
admission as to the materiality of any such information that it
is furnishing.
| Item 9.01 | Financial Statements and Exhibits. |
| (d) | Exhibits. |
| 99.01 |
Press release, dated May 15, 2017, issued by Tonix Pharmaceuticals Holding Corp.* |
| 99.02 | Corporate Presentation by the Company for May 2017* |
* Furnished herewith.
TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Recent Trading Information
TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) closed its last trading session up +0.09 at 4.11 with 79,531 shares trading hands.
